Introducing i.Mune™ Tests

i.Mune™ TBNK [CE]

Relative and absolute quantification* of CD3+/CD4+/CD8+ T-, B- and NK lymphocytes from fresh blood


i.Mune™ NEO (in development)

Relative quantification of CD3+ T-, B- and NK lymphocytes, TSDR+ regulatory T cells (Treg) and neutrophils from dried blood spots (DBS).

 

(TSDR = Treg Specific De-methylated Region)


i.Mune™ PID (in development)

Relative and absolute quantification* of CD3+/CD4+/CD8+ T-, B-, NK cells, Treg, neutrophils and monocytes from dried blood spots (DBS) or fresh blood


*Relative quantification (%) is possible for all sample types; absolute quantification (cells/µl) currently for fresh blood, only

 

i.Mune™ is a registered trademark of Epimune GmbH, in Europe, USA and/or other selected countries, with trademarks pending in the US. All other trademarks, brands, names contained herein are the property of their respective owners.